Rennova Health, Inc. (NASDAQ:RNVA) Files An 8-K Other Events
Item 8.01.
| Other Events. |
On May 25, 2017, the Company issued a press release announcing
the postponment of its Special Meeting of Stockholders from May
26, 2017 to June 2, 2017. A copy of the press release is attached
hereto as Exhibit 99.1, and is incorporated by reference herein.
| Item 9.01. | Financial Statements and Exhibits. |
(d)Exhibits
| Exhibit No. | Exhibit Description |
| 99.1 | Press Release dated May 25, 2017 |
About Rennova Health, Inc. (NASDAQ:RNVA)
Rennova Health, Inc. (Rennova), formerly CollabRx, Inc., is a provider of diagnostics and supportive software solutions to healthcare providers. The Company operates in three segments: clinical laboratory operations, supportive software solutions, and decision support and informatics operations. The Company is a healthcare enterprise that delivers products and services, including laboratory diagnostics, healthcare technology solutions, and revenue cycle management and intends to provide financial services, to medical providers. Rennova’s principal line of business is clinical laboratory blood and urine testing services. It is also engaged in the provision of urine drug toxicology testing to physicians, clinics and rehabilitation facilities in the United States. Its clinical laboratories include Biohealth Medical Laboratory, Inc.; Alethea Laboratories, Inc.; International Technologies, LLC; EPIC Reference Labs, Inc., and Epinex Diagnostics Laboratories, Inc. Rennova Health, Inc. (NASDAQ:RNVA) Recent Trading Information
Rennova Health, Inc. (NASDAQ:RNVA) closed its last trading session up +0.010 at 0.510 with 270,994 shares trading hands.
